Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

675 results
  1. ... of the initial ART while awaiting results of drug resistance testing. 23 For women who present in labor with unknown HIV status, rapid testing with initiation of maternal (intravenous ...
  2. ... P. MARTIN, T. R. EASTERLING CONSENSUS STATEMENT Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection: Recommendations of an International AIDS Society- ...
  3. ... that may delay or eliminate development of individual drug resistance. . . ¢ To share relevant information gained from preclinical and clinical testing of HIV antiviral compounds so that the most appropriate combinations ...
  4. ... order to prevent or delay the onset of resistance to individual compounds. Objectives: « Faciitate clinical testing of HIV antivirel compounds in combination which may delay or eliminate development of individual drug resistence. . ¢ ° © Share relevant information gained from preclinical and ...
  5. ... and control for immunological and clinical HIV status, HIV viral replication rates, prior history ... much more research already exists regarding treatment ...
  6. NLM Digital Collections - Chronic hepatitis C virus infection : developing direct-acting antiviral drugs for treatment 
    Publication: Silver Spring, MD : Center for Drug Evaluation and Research, November 2017
    ... analogue NS5B polymerase inhibitors) should be assessed before testing combinations of the drugs in HIV-1/HCV co-infected patients. f. Resistance and cross-resistance Sponsors should examine in cell ...
  7. ... considerably more potent in blocking © growth of the HIV virus in human cells ... early testing of other non-nucleoside reverse transcriptase inhibitors, Upjohn ...
  8. NLM Digital Collections - Cytomegalovirus in transplantation : developing drugs to treat or prevent disease 
    Publication: Silver Spring, MD : Center for Drug Evaluation and Research, May 2020
    ... HIV-1 because these may be used in HIV-1- infected patients. If the drug ... use in testing. FDA encourages sponsors to consult with review divisions ...
  9. ... from the outset that the unusual plasticity of HIV, with its antigenic and ... ‘ of testing. The expectation of rapid vaccine development was set ...
  10. ... the Commission Report, such as increased counseling and testing, reporting of ... of HIV patients, drug abusers, and group homes for HIV-infected infants ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last